Guidelines on treatment of stage IIIB non-small cell lung cancer

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 221S-225S

  Jett, James R ^a   Scott, Walter J ^b   Rivera, M Patricia ^c   Sause, William T ^d  

^a MAYO CLINIC   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

NSCLC stage IIIB; Stage IIIB; Unresectable lung cancer; Unresectable NSCLC

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN; NAVELBINE; PLATINUM; VINBLASTINE; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE SEVERITY; ESOPHAGITIS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037246684     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1_suppl.221S     Document Type: Article

References (25)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
2. British Thoracic Society, of Cardiothoracic Surgeons of Great Britain, and Ireland Working Party. Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89-108
3. Deslauriers J, Brisson J, Cartier R, et al. Carcinoma of the lung: evaluation of satellite nodules as a factor influencing prognosis after resection. Thorac Cardiovasc Surg 1989; 97:504-512
4. Urschel JD, Urschel DM, Anderson TM, et al. Prognostic implications of pulmonary satellite nodules: are the 1997 staging revisions appropriate? Lung Cancer 1998; 21:83-87
5. Mathieson DJ, Grillo HC. Crainal resection for bronchogenic carcinoma. Thorac Cardiovasc Surg 1991; 102:16-22
6. Darteville PG, Khalife J, Chapelier A, et al. Tracheal sleeve pneumonectomy for bronchogenic carcinoma: a report of 55 cases. Ann Thorac Surg 1988; 46:68-72
7. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiation therapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995; 13:1880-1892
8. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation vs radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323:940-945
9. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 Trial. J Natl Cancer Inst 1996; 88:1210-1215
10. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311:899-909
11. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer: a meta-analysis. Ann Intern Med 1996; 125:723-729
12. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone vs combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer: a meta-analysis. Cancer 1995; 76:593-601
13. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 1997; 15:2996-3018
14. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group phase III randomized study to compare hyperfractionation with two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First Report of RTOG 9003. Int J Radiat Biol Phys 2000; 48:7-16
15. Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 2000; 117:358-364
16. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997; 37:259-267
17. Cancer Care Ontario Practice Guideline Initiative GPG 7-12. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. Available at http://hiru.mcmaster.ca/ccopgi/guidelines/lung/cpg7_12f.html. Accessed December 18, 2002
18. Stella P, Marks R, Schild S, et al. Phase III trial of chemotherapy either standard radiotherapy or accelerated hyper-fractionated thoracic radiotherapy for stage III non-small cell lung cancer[abstract]. Proc Amer Soc Clin Oncol 2001; 20:312a (1245)
19. Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) vs conventional radiotherapy in non-small cell lung cancer: a randomized multicentre trial. Lancet 1997; 350:161-165
20. Saunders M, Dische S, Barrett A, et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) vs conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicentre trial. Radiother Oncol 1999; 52:137-148
21. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Cancer 1980; 45:2744-2753
22. LeChevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone vs combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83:417-423
23. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent vs sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17:2692-2699
24. Curran WJ Jr, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: initial report of the Radiation Therapy Oncology Group 9410 [abstract]. Proc Amer Soc Clin Oncol 2000; 19:484a (1891)
25. Pierre F, Maurice P, Gilles R, et al. A randomized phase III trial of sequential chemoradiotherapy in locally advanced non-small cell lung cancer [abstract]. Proc Amer Soc Clin Oncol 2001; 20:312a